The PI3K/AKT/mTOR pathway is abnormally activated in a variety of tumor cells, regulating tumor occurrence, development, drug resistance, and the Warburg effect (Jiang 2017; Shen et al. 2017). This evidence concerns the gene AKT1 and neoplasm.